Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Dec;48(6):859–861. doi: 10.1038/bjc.1983.278

Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent.

D L McCormick, R C Moon
PMCID: PMC2011564  PMID: 6652027

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayer B. M., Kruth H. S., Vaughan M., Beaven M. A. Arrest of cultured cells in the G1 phase of the cell cycle by indomethacin. J Pharmacol Exp Ther. 1979 Jul;210(1):106–111. [PubMed] [Google Scholar]
  2. Bennett A., Berstock D. A., Carroll M. A. Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy. Br J Cancer. 1982 May;45(5):762–768. doi: 10.1038/bjc.1982.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berstock D. A., Houghton J., Bennett A. Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis. Cancer Treat Rev. 1979 Jun;6 (Suppl):69–71. doi: 10.1016/s0305-7372(79)80015-8. [DOI] [PubMed] [Google Scholar]
  4. Boynton A. L., Whitfield J. F. Possible involvement of arachidonic acid in the initiation of DNA synthesis by rat liver cells. Exp Cell Res. 1980 Oct;129(2):474–478. doi: 10.1016/0014-4827(80)90518-2. [DOI] [PubMed] [Google Scholar]
  5. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. Drugs. 1979 Dec;18(6):417–438. doi: 10.2165/00003495-197918060-00001. [DOI] [PubMed] [Google Scholar]
  6. Droller M. J., Perlmann P., Schneider M. U. Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells. Cell Immunol. 1978 Aug;39(1):154–164. doi: 10.1016/0008-8749(78)90090-4. [DOI] [PubMed] [Google Scholar]
  7. Glaser M. Indomethacin-sensitive suppressor cells regulate the cell-mediated cytotoxic response to SV 40-induced tumor-associated antigens in mice. Eur J Immunol. 1980 Jul;10(7):489–495. doi: 10.1002/eji.1830100702. [DOI] [PubMed] [Google Scholar]
  8. Higgs G. A., Eakins K. E., Mugridge K. G., Moncada S., Vane J. R. The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageenin-induced inflammation. Eur J Pharmacol. 1980 Aug 22;66(1):81–86. doi: 10.1016/0014-2999(80)90297-6. [DOI] [PubMed] [Google Scholar]
  9. Leaper D. J., French B. T., Bennett A. Breast cancer and prostaglandins: a new approach to treatment. Br J Surg. 1979 Oct;66(10):683–686. doi: 10.1002/bjs.1800661004. [DOI] [PubMed] [Google Scholar]
  10. McCormick D. L., Adamowski C. B., Fiks A., Moon R. C. Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res. 1981 May;41(5):1690–1694. [PubMed] [Google Scholar]
  11. Miyamoto-Tiaven M. J., Hillyard L. A., Abraham S. Influence of dietary fat on the growth of mammary ducts in BALB/c mice. J Natl Cancer Inst. 1981 Jul;67(1):179–188. [PubMed] [Google Scholar]
  12. Narisawa T., Sato M., Tani M., Kudo T., Takahashi T., Goto A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res. 1981 May;41(5):1954–1957. [PubMed] [Google Scholar]
  13. Nozu K. Flurbiprofen: highly potent inhibitor of prostaglandin synthesis. Biochim Biophys Acta. 1978 Jun 23;529(3):493–496. [PubMed] [Google Scholar]
  14. Pollard M., Luckert P. H. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science. 1981 Oct 30;214(4520):558–559. doi: 10.1126/science.7291992. [DOI] [PubMed] [Google Scholar]
  15. Powles T. J., Alexander P., Millar J. L. Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of P.G. synthesis. Biochem Pharmacol. 1978 May 1;27(9):1389–1392. doi: 10.1016/0006-2952(78)90127-2. [DOI] [PubMed] [Google Scholar]
  16. Rose D. P., Pruitt B., Stauber P., Ertürk E., Bryan G. T. Influence of dosage schedule on the biological characteristics of N-nitrosomethylurea-induced rat mammary tumors. Cancer Res. 1980 Feb;40(2):235–239. [PubMed] [Google Scholar]
  17. Verma A. K., Ashendel C. L., Boutwell R. K. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1980 Feb;40(2):308–315. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES